To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

Differentiation therapy

From Wikipedia, the free encyclopedia

Differentiation therapy
Specialtyoncology

Differentiation therapy is a method to treating advanced cancers in which malignant cells are encouraged to differentiate into more mature forms using pharmacological agents. The basis of the therapy stems from the tendency of malignant tumor cells to assume a less specialized, stem cell-like dedifferentiated state.[1]

YouTube Encyclopedic

  • 1/1
    Views:
    1 462
  • Making Gasoline from CO2 Using E.Coli: Spencer Glantz

Transcription

Leukemia

The approach was motivated by noticing that leukemia cells fail to differentiate and fully mature.[2]

By 2001 encouraging clinical results were seen.[3]

The first differentiation agent found to be successful was all-trans-retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).[1]

Other cancers

The process of cancer spreading (metastasis) involves tumour cells undergoing an epithelial-to-mesenchymal transition (EMT) to invade and spread, followed by a mesenchymal-to-epithelial transition (MET) at remote sites.

Other agents investigated (pre-clinically) to encourage MET include cholera toxin (CTx) and forskolin (Fsk).[4]

References

  1. ^ a b Sell, Stewart. (2004). "Stem cell origin of cancer and differentiation therapy". Critical Reviews in Oncology/Hematology. 51 (1): 1–28. doi:10.1016/j.critrevonc.2004.04.007. PMID 15207251.
  2. ^ Nowak, D.; Stewart, D.; Koeffler, H. P. (2009). "Differentiation therapy of leukemia: 3 decades of development". Blood. 113 (16): 3655–65. doi:10.1182/blood-2009-01-198911. PMC 2943835. PMID 19221035.
  3. ^ Leszczyniecka, M; Roberts, T; Dent, P; Grant, S; Fisher, P. B. (2001). "Differentiation therapy of human cancer: Basic science and clinical applications". Pharmacology & Therapeutics. 90 (2–3): 105–56. doi:10.1016/s0163-7258(01)00132-2. PMID 11578655.
  4. ^ Pattabiraman, D. R.; Bierie, B.; Kober, K. I.; Thiru, P.; Krall, J. A.; Zill, C.; Reinhardt, F.; Tam, W. L.; Weinberg, R. A. (2016). "Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability". Science. 351 (6277): aad3680. doi:10.1126/science.aad3680. PMC 5131720. PMID 26941323.


This page was last edited on 11 March 2022, at 02:30
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.